Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils.
Magari H, Shimizu Y, Inada K, Enomoto S, Tomeki T, Yanaoka K, Tamai H, Arii K, Nakata H, Oka M, Utsunomiya H, Tsutsumi Y, Tsukamoto T, Tatematsu M, Ichinose M. Magari H, et al. Among authors: oka m. Biochem Biophys Res Commun. 2005 Aug 26;334(2):606-12. doi: 10.1016/j.bbrc.2005.06.132. Biochem Biophys Res Commun. 2005. PMID: 16009342
Gastric acid reduction leads to an alteration in lower intestinal microflora.
Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, Inoue I, Maekita T, Ueda K, Enomoto S, Iguchi M, Yanaoka K, Tamai H, Akimoto S, Nomoto K, Tanaka R, Ichinose M. Kanno T, et al. Among authors: oka m. Biochem Biophys Res Commun. 2009 Apr 17;381(4):666-70. doi: 10.1016/j.bbrc.2009.02.109. Epub 2009 Feb 25. Biochem Biophys Res Commun. 2009. PMID: 19248769
Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion.
Yanaoka K, Oka M, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Maekita T, Inoue I, Ueda K, Utsunomiya H, Iguchi M, Tamai H, Fujishiro M, Nakamura Y, Tsukamoto T, Inada K, Takeshita T, Ichinose M. Yanaoka K, et al. Among authors: oka m. Int J Cancer. 2010 Mar 15;126(6):1467-73. doi: 10.1002/ijc.24862. Int J Cancer. 2010. PMID: 19711347 Clinical Trial.
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Ohata H, Fujishiro M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Among authors: oka m. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):838-45. doi: 10.1158/1055-9965.EPI-07-2762. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18398025 Clinical Trial.
Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M. Yanaoka K, et al. Among authors: oka m. Int J Cancer. 2009 Dec 1;125(11):2697-703. doi: 10.1002/ijc.24591. Int J Cancer. 2009. PMID: 19610064
Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study.
Inoue I, Mukoubayashi C, Yoshimura N, Niwa T, Deguchi H, Watanabe M, Enomoto S, Maekita T, Ueda K, Iguchi M, Yanaoka K, Tamai H, Arii K, Oka M, Fujishiro M, Takeshita T, Iwane M, Mohara O, Ichinose M. Inoue I, et al. Among authors: oka m. Int J Cancer. 2011 Dec 1;129(11):2704-11. doi: 10.1002/ijc.25931. Epub 2011 Mar 8. Int J Cancer. 2011. PMID: 21225622
Rebamipide induces dendritic cell recruitment to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-exposed rat gastric mucosa based on IL-1β upregulation.
Yamamichi N, Oka M, Inada K, Konno-Shimizu M, Kageyama-Yahara N, Tamai H, Kato J, Fujishiro M, Kodashima S, Niimi K, Ono S, Tsutsumi Y, Ichinose M, Koike K. Yamamichi N, et al. Among authors: oka m. Biochem Biophys Res Commun. 2012 Jul 20;424(1):124-9. doi: 10.1016/j.bbrc.2012.06.087. Epub 2012 Jun 23. Biochem Biophys Res Commun. 2012. PMID: 22732404
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M. Yoshida T, et al. Among authors: oka m. Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3. Int J Cancer. 2014. PMID: 24009139
2,312 results